| Identification | Back Directory | [Name]
NS 1619 | [CAS]
153587-01-0 | [Synonyms]
NS 161
NS 1619
NS1619;NS 1619
NS 1619 (1,3-DIHYDRO-1-(2-HYDROXY-5-(TRI FLUOROMETHYL)PHEN
1-(2-hydroxy-5-(trifluoroMethyl)phenyl)-5-(trifluoroMethyl)-1H-b
1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1H-benzo[d]imidazol-2(3H)-one
1,3-DIHYDRO-1-[2-HYDROXY-5-(TRIFLUOROMETHYL)PHENYL]-5-(TRIFLUOROMETHYL)-2H-BENZIMIDAZOL-2-ONE
1-[2-Hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-1,3-dihydro-2H-benzimidazol-2-one
2H-Benzimidazol-2-one, 1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-
1-[2-Hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one | [Molecular Formula]
C15H8F6N2O2 | [MDL Number]
MFCD00928190 | [MOL File]
153587-01-0.mol | [Molecular Weight]
362.23 |
| Chemical Properties | Back Directory | [density ]
1.563±0.06 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,2-8°C | [solubility ]
45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.47 mg/mL
| [form ]
solid
| [pka]
8.32±0.48(Predicted) | [color ]
white
| [Water Solubility ]
45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.47mg/mL
ethanol: 26.6mg/mL
0.1 M NaOH: 5.2mg/mL
DMSO: 5.3mg/mL
H2O: insoluble | [InChI]
InChI=1S/C15H8F6N2O2/c16-14(17,18)7-1-3-10-9(5-7)22-13(25)23(10)11-6-8(15(19,20)21)2-4-12(11)24/h1-6,24H,(H,22,25) | [InChIKey]
YLFMCMWKHSDUCT-UHFFFAOYSA-N | [SMILES]
C1(=O)N(C2=CC(C(F)(F)F)=CC=C2O)C2=CC=C(C(F)(F)F)C=C2N1 |
| Hazard Information | Back Directory | [Uses]
NS 1619 is a large conductance calcium-activated potassium channels (BKCa) activator and has been shown to induce precondition in the heart. | [Definition]
ChEBI: A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It i
an opener/activator of the large-conductance calcium-activated potassium channel (Bkca). | [Biochem/physiol Actions]
NS 1619 is a selective large conductance Ca2+-activated K+-channel activator. The compound is known for its vasodilating and anti-proliferative properties. It is studied that NS 1619 can protect cardiac muscle against ischemia and reperfusion injury. | [in vivo]
Opening of KCa channels with NS-1619 (1 mg/kg; i.p.) can delay protection in mouse hearts[3]. | Animal Model: | Adult male outbred ICR mice[3] | | Dosage: | 1 mg/kg | | Administration: | Pretreated i.p. 24 h before I/R | | Result: | Pretreatment induced delayed protection 24 h later.
Resulted in significant cardioprotection 24 h later, i.e., infarct size was reduced from 38.8 ± 3.7% to 19.8 ± 2.9%.
|
| [storage]
+4°C |
|
|